NOVOCURE LTD (NVCR)

Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference

Why NovoCure Stock Was Winning Big This Week

Novocure Has Already Doubled in 2024. Can It Soar Higher in 2025?

Notable Monday Option Activity: PL, NVCR, FSLR

Novocure Launches 40% After Pancreatic Cancer Treatment Succeeds

The company is soon to seek regulatory approval in the U.S. and abroad.

Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer

Novocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer

Novocure to Participate in Upcoming Investor Conferences

Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma

FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma

NovoCure (NVCR) Shares Cross Below 200 DMA

NovoCure (NVCR) Q3 2024 Earnings Call Transcript

NVCR earnings call for the period ending September 30, 2024.

Novocure Appoints Christoph Brackmann as Chief Financial Officer

Novocure Reports Third Quarter 2024 Financial Results

Noteworthy Wednesday Option Activity: ABUS, M, NVCR

Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment

The company could have a long path ahead to reimbursement and, ultimately, sales.

NovoCure Breaks Above 200-Day Moving Average - Bullish for NVCR

FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer

Novocure to Report Third Quarter 2024 Financial Results

Novocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy

Why NovoCure Stock Dived by 13% This Week

Investors found the announced changes to the company's C-suite unsettling.

NVCR November 15th Options Begin Trading

Novocure Announces Planned CEO Transition

Novocure to Participate in 2024 Wells Fargo Healthcare Conference

Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer

Chips, Glorious Chips!

Someone's gotta make 'em, and someone's gotta buy 'em.